DGIdb - CTAG1B Gene Record

CTAG1B 1485

Alternate Names:

1485
CANCER/TESTIS ANTIGEN 1B
CTAG1B
CT6.1
CTAG
CTAG1
ESO1
LAGE-2
LAGE2B
NY-ESO-1
300156
2491
ENSG00000184033
OTTHUMG00000024232
1278

Gene Info:

Gene Biotype	PROTEIN_CODING

(0 More Sources)

Gene Categories: Category Details

Publications:

Weiser et al., Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1., J. Immunother.

ROMIDEPSIN CTAG1B

Interaction Score: 6.71

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11265773

Sources:
NCI

Ensembl: ENSG00000184033
- Version: 101_38
Alternate Names:

CTAG1B Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:
CIViC: CTAG1B
- Version: 14-September-2020
Alternate Names:

1485 Entrez Gene ID

1278 CIViC Gene ID

Gene Info:

Publications:

Rapoport et al., 2015, NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma., Nat. Med.

NCI: CTAG1B

Version: 14-September-2017

Alternate Names:

Gene Info:

Publications:

Bownds et al., Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution., J. Immunother.

Weiser et al., Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1., J. Immunother.